Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to CHMP Issues Positive Opinion For Merck���s VICTRELISTM (boceprevir), Oral Hepatitis C Virus (HCV) Protease Inhibitor
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account